First-in-human study of YR011 tablet in healthy volunteers
This study tests a new oral medication called YR011 for the first time in people. It aims to find a safe dose and see how the body handles it, which may help treat future conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your body mass index (BMI) must be between 18 and 32, and you must weigh less than 120 kg.
- You must be generally healthy, with no major medical conditions.
- If you are a man, you must use a condom or abstain from sex during the trial and for 3 months after. If you are a woman who can become pregnant, you must use highly effective birth control for at least 3 weeks before and during the trial, plus 3 months after.
- You must not have certain health issues like diabetes, thyroid problems, or a history of cancer in the last 5 years.
- You must not be taking any other medications, including over-the-counter drugs or herbal supplements, for at least 14 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication in healthy adults to see how safe it is and how the body handles it. It's an early-stage study, so participants help determine the right dose for future patients.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
Hear when a new Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.